Risk factors
Niagen Bioscience (NAGE) risk factors
Item 1A of every Niagen Bioscience, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors49 risks1 new1 dropped7 reworded
Payment processing and HSA/FSA compliance risks were added to operations.
Filed Mar 04, 2026 - FY2024 10-K risk factors49 risks
Niagen Bioscience faces concentration risk from Tru Niagen and reliance on wellness and IV therapy market trends. The company depends heavily on third-party contract manufacturers, outsourcing facilities, and key personnel. Extensive government regulations across dietary supplements and pharmaceuticals significantly impact operations.
Filed Mar 04, 2025